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AbstrACt
Objective To examine the factors associated with 
receiving surgery for heavy menstrual bleeding (HMB) in 
England and Wales.
Design National cohort study.
setting National Health Service hospitals.
Participants Women with HMB aged 18–60 who had a 
new referral to secondary care.
Methods Patient-reported data linked to administrative 
hospital data. Risk ratios (RR) estimated using 
multivariable Poisson regression.
Primary outcome measure Surgery within 1 year of first 
outpatient clinic visit.
results 14 545 women were included. At their first clinic 
visit, mean age was 42 years, mean symptom severity 
score was 62 (scale ranging from 0 (least) to 100 (most 
severe)), 73.9% of women reported having symptoms for 
>1 year and 30.4% reported no prior treatment in primary 
care. One year later, 42.6% had received surgery. Of these, 
57.8% had endometrial ablation and 37.2% hysterectomy. 
Women with more severe symptoms were more likely 
to have received surgery (most vs least severe quintile, 
33.1% vs 56.0%; RR 1.6, 95% CI 1.5 to 1.7). Surgery was 
more likely among those who reported prior primary care 
treatment compared with those who did not (48.0% vs 
31.1%; RR 1.5, 95% CI 1.4 to 1.6). Surgery was less 
likely among Asian and more likely among black women, 
compared with white women. Surgery was not associated 
with socioeconomic deprivation.
Conclusions Receipt of surgery for HMB depends on 
symptom severity and prior treatment in primary care. 
Referral pathways should be locally audited to ensure 
women with HMB receive care that addresses their 
individual needs and preferences, especially for those who 
do not receive treatment in primary care.
IntrODuCtIOn 
Heavy menstrual bleeding (HMB) affects 
one in four women of reproductive age. It 
is a condition that impairs the quality of life 
of many women who are otherwise healthy.1 
Every year in England and Wales, an esti-
mated 50 000 women with HMB are referred 
to secondary care provided by the National 
Health Service (NHS).2 This constitutes 
approximately 20% of referrals to specialist 
gynaecology services,3 and approximately 
28 000 women undergo surgical treatment.4 
In the majority of women, the cause of their 
HMB is not known.5 
Medical treatments for HMB include (oral) 
medication and the levonorgestrel -releasing 
intrauterine system(LNG-IUS). Surgical treat-
ment, including endometrial ablation (EA) 
and hysterectomy, is an option if medical 
treatment is ineffective or undesirable.1 5 6 A 
systematic review of randomised clinical trials 
suggest that EA, hysterectomy and LNG-IUS 
all reduce HMB and are more acceptable 
to most women than oral medication.1 The 
strengths and limitations of this study
 ► This study uses national audit data from England 
and Wales to examine initial treatments for heavy 
menstrual bleeding immediately after referral to 
secondary care.
 ► The sample is relatively large allowing comparisons 
between minority ethnic groups.
 ► Linking audit data with administrative hospital data 
also allowed comparisons between socioeconomic 
groups.
 ► The recruitment rate of 30% was not as high as de-
sired, but the characteristics of those recruited were 
broadly representative of the UK population in terms 
of ethnicity and age.
 ► The collection of patient-reported symptom severity 
addresses a knowledge gap about how women feel 
about their heavy menstrual bleeding and the treat-
ment they receive.
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review found that surgical treatment is most effective 
over the short term although the quality of included trials 
was limited.1 Hysterectomy will stop HMB but around 
3% of women experience potentially serious postopera-
tive complications.7 EA and LNG-IUS appear to be safe, 
acceptable and effective treatments for HMB although 
some women who have EA will require a repeat proce-
dure.1 8–10
Since the early 1990s, there has been a steady increase 
in the use of EA rather than hysterectomy in women who 
have surgical treatment for HMB.11 Since 2004, more EA 
procedures than hysterectomies have been conducted 
in England.4 11–13 Previous studies have found regional 
variations in rates of surgery for HMB in England large 
enough to suggest scope for improvements in HMB 
management.3 12 14 15 In addition, women from socioeco-
nomically deprived areas report more severe HMB at 
their first outpatient gynaecology visit16 and higher rates 
of hysterectomy for HMB, than women living in the least 
deprived areas,8 potentially reflecting inequitable access 
to secondary care and use of surgery for HMB.
In this paper, we investigate the factors that determine 
whether women who have been referred to secondary 
care for HMB get surgical treatment. We use patient-re-
ported data from the National HMB Audit linked to 
administrative hospital databases: Hospital Episode Statis-
tics (HES) and the Patient Episode Database for Wales 
(PEDW). We explore the impact that symptom severity, 
treatment received in primary care and patient character-
istics including age, ethnicity and socioeconomic depri-
vation have on the chance that women receive surgical 
treatment in the first year after their referral to secondary 
care.
MethODs
Data
Women aged between 18 and 60 years in England and 
Wales who had a new referral for HMB to a gynae-
cology outpatient clinic of an NHS hospital were eligible 
to participate in the National HMB Audit.2 4 13 17 The 
National HMB Audit took place between 2010 and 2014, 
with an estimated recruitment rate of 32%.2 17 National 
HMB Audit data were linked at the patient level (by a 
trusted third party) to HES and PEDW, administrative 
databases containing records of all admissions to NHS 
hospitals in England and Wales to provide data on treat-
ments received in secondary care.
Measures
Women were considered to have had a surgical procedure 
for HMB (the study outcome) if any HES/PEDW proce-
dure field described abdominal or vaginal hysterectomy, 
EA, myomectomy or uterine artery embolisation (UAE), 
recorded using UK Office for Population Censuses and 
Surveys classification, fourth revision codes.18 For women 
who underwent a surgical procedure for HMB, informa-
tion on underlying conditions was available from HES/
PEDW, recorded using International Classification of 
Diseases, 10th Revision codes.19 These were grouped 
as: ‘endometriosis (with or without uterine fibroids or 
polyps)’, ‘uterine fibroids and/or polyps (no endome-
triosis)’ and ‘no obvious cause’. Women without codes 
for uterine fibroids, polyps or endometriosis, but with 
code(s) indicating excessive or irregular menstrual 
bleeding, were classed as having no obvious cause of their 
HMB. The codes used to define surgery and underlying 
conditions are detailed in the online supplementary 
appendix S1.
Women who gave informed consent completed a 
baseline questionnaire (in the gynaecology outpatient 
clinic of an NHS hospital before their consultation) on 
age (categorised as 18–34, 35–39, 40–44, 45–49, 50–60), 
ethnicity (grouped as ‘white’, ‘Asian or Asian British’, 
‘black or black British’ and ‘other’ (combining ‘Chinese’, 
‘mixed’ and ‘other’), duration and severity of HMB 
symptoms, obstetric history (analysed as ‘nulliparous’ 
or ‘parous’), prior HMB treatment and comorbidities. 
To capture comorbidities (grouped: 0, 1 and 2 or more) 
women were asked ‘Have you been told by a doctor that 
you have any of the following?’ with the response options: 
heart disease, high blood pressure, lung disease, diabetes, 
depression, thyroid disorder, kidney disease and cancer 
(in the last 5 years). Body mass index (BMI, grouped: <25, 
25–30 and ≥30) was derived from self-reported height 
and weight.20 The Index of Multiple Deprivation (IMD), 
an area-level measure of relative socioeconomic depri-
vation, was extracted from HES/PEDW and analysed as 
quintiles (1=most deprived areas, 5=least deprived areas) 
according to the national distribution. Further informa-
tion is given in the online supplementary appendix S2.
Women were asked: ‘How long have you had symptoms 
of HMB?’ (‘2 months or less’, ‘>2 months but <1 year’, 
‘>1 year’ or ‘don’t know’), analysed as ‘<1 year’, ‘≥1 year’. 
Symptom severity scores were derived from the Uterine 
Fibroid Symptom and Quality of Life (UFS-QOL) ques-
tionnaire adapted for the HMB Audit.21 Scores could 
range from 0 (least severe, best possible score) to 100 
(most severe, worst possible score), analysed in quintiles. 
Further information is provided in the online supple-
mentary appendix S3.
statistical analysis
We present descriptive statistics (means and proportions) 
of patient and HMB-related characteristics and treatment 
received in the year after the first outpatient clinic visit for 
HMB. For descriptive statistics, those who had more than 
one surgical treatment in the year following their first 
outpatient clinic visit were categorised by the last likely 
surgical treatment (according to clinical experience and 
protocol).
We used multivariable Poisson regression with robust 
SEs to estimate risk ratios (RR) that represent the associ-
ations between patient and HMB-related characteristics 
reported by women at their first gynaecology outpatient 
clinic visit and receiving surgical treatment in the first 
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year following this.22 We chose to report risk ratios (RRs) 
rather than ORs because the latter are more difficult to 
interpret, especially if the proportions being compared 
are relatively large. In a secondary analysis, we examined 
the associations between these characteristics and whether 
women received EA or hysterectomy among those having 
one of these procedures. Women who received both EA 
and a hysterectomy in the year following their first outpa-
tient visit (n=699) were included in the EA treatment 
group for this analysis because EA was the first procedure. 
We tested for interaction between both ethnicity and BMI 
and HMB-related condition.
Levels of missing data were low (<3%) for the majority 
of variables but 7% of women were missing ethnicity data 
and 23% were missing height or weight data required 
to derive BMI (table 1). For regression analyses missing 
values were imputed using multiple imputation by 
chained equations23 with statistical coefficients obtained 
using 10 imputed data sets, pooled using Rubin’s rules.24 
Analyses were performed in Stata V.15.
Patient involvement
The National HMB Audit was supported by a clinical 
reference group which included lay members and patient 
representatives. The lay members and patient represen-
tatives provided input to the design of the study and 
interpretation of the results, and contributed to the 
dissemination plan. The clinical reference group met on 
a regular basis for the duration of the audit. Women with 
HMB also participated in a pilot study to assess the logis-
tical issues of the prospective National HMB Audit. This 
informed the design of written materials and key proce-
dures for the audit. Ninety-six women with HMB also 
participated in interviews to refine and psychometrically 
evaluate the adapted UFS-QOL instrument.
results
Description of the cohort
A total of 15 325 eligible women completed the ques-
tionnaire at their first visit to a gynaecology outpatient 
clinic. Up to 14 545 women (94.9%) could be linked to 
HES or PEDW for information on surgical treatments 
and deprivation. Of these women, 11.6% (n=1578) 
reported minority ethnic backgrounds (black, n=571; 
Asian, n=731), with the distribution of ethnicities broadly 
representative of the UK population.25 The mean age of 
women was 42.4 years (SD: 7.6) and the mean BMI was 
27.3 kg/m2 (SD: 5.4) (table 1). The majority of women 
had given birth (83.1%, n=11 727) and one-third reported 
comorbidities (33.8%, n=4925). The mean score for 
symptom severity at first outpatient clinic visit was 61.8 
(SD: 21.3) and this score ranged from 34.3 (SD: 10.8) in 
the least severe symptoms quintile to 93.8 (SD: 5.1) in the 
most severe symptoms quintile. Almost three-quarters of 
women reported HMB symptoms for more than 1 year 
and nearly a third (30.4%) reported that they had not 
Table 1 Characteristics of women at their initial HMB 
outpatient visit
Denominator (n=14 545)
% (n) unless 
otherwise 
stated
Age (years), mean (SD) 42.4 (7.6)
Age group (years)
  18–34 14.8 (2155)
  35–39 12.9 (1881)
  40–44 26.6 (3870)
  45–49 31.3 (4554)
  50–60 14.3 (2085)
Ethnicity
  White 88.4 (11 987)
  Asian or Asian British 4.2 (731)
  Black or black British 5.4 (571)
  Other 2.0 (276)
  Missing 6.7 (980)
Socioeconomic deprivation (IMD*)
  Quintile 1 (most deprived) 23.5 (3418)
  Quintile 2 21.7 (3159)
  Quintile 3 20.2 (2944)
  Quintile 4 18.7 (2720)
  Quintile 5 (least deprived) 15.8 (2304)
BMI, mean (SD) 27.3 (5.4)
BMI categories
  <25 39.5 (4424)
  25–30 31.7 (3569)
  ≥30 28.8 (3226)
  Missing 23.0 (3346)
Parity
  Nulliparous 16.9 (2378)
  Parous 83.1 (11727)
  Missing 3.0 (440)
Number of comorbidities
  0 66.1 (9620)
  1 25.4 (3701)
  ≥2 8.4 (1224)
Overall health
  Excellent/very good 37.4 (5356)
  Good 42.0 (6009)
  Fair/poor 20.7 (2958)
  Missing 1.5 (222)
Symptom severity at baseline
  Severity score at baseline (overall), mean 
(SD) 61.8 (21.3)
  Severity score at baseline (quintiles), 
mean (SD)
Continued
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received medical treatment for their HMB in primary 
care before referral (table 1).
treatment received in the year following first outpatient clinic 
visit
Approximately 40% of women received surgical treat-
ment for HMB in the year following their first outpa-
tient clinic visit (42.6%, table 2), with most of those 
undergoing EA (57.8%) or hysterectomy (37.2%). 
The small number of women receiving UAE (n=129) 
or myomectomy (n=179) precluded further analysis of 
these groups separately.
receipt of surgical treatment by women’s characteristics
Symptom severity at first outpatient clinic visit and 
medical treatment received for HMB in primary care 
were associated with surgical treatment received in the 
year following first outpatient clinic visit. The rate of 
surgical treatment was higher among those reporting 
the most severe symptoms than among those reporting 
the least severe symptoms (RR comparing the most to 
the least severe symptoms quintile 1.5, 95% CI 1.4 to 1.6, 
table 2). Receipt of surgery was highest among those aged 
40–44 and 45–49 years, where half (49.9%) had received 
surgery, and lowest among women aged 18–34 years 
(18.4%, table 2), despite similar mean symptom severity 
scores for the 18–34 year-olds (63.3, SD: 20.8) and the 
40–45 and 45–49 year-olds (62.7, SD: 21.2 and 61.6, SD: 
21.2, data not shown).
The rate of surgery was higher among women who 
reported prior treatment in primary care than among 
those who did not (RR 1.4, 95% CI 1.4 to 1.5, table 2), 
and among those who reported a longer duration of 
symptoms at their initial outpatient visit for HMB (RR 1.3, 
95% CI 1.2 to 1.4). Among women who reported that they 
had received prior treatment in primary care, the propor-
tion that had received surgery was highest among those 
reporting the most severe symptoms in all age groups, 
and use of surgery increased with age up to ages 40–49 
years (figure 1). Among those who reported that they 
had not received prior treatment in primary care these 
patterns were broadly similar, although the relationship 
between symptom severity and surgery was less marked 
for women aged 35–39 years where a similar proportion 
of women in each of the three most severe symptom 
quintiles received surgery (figure 1). The proportion of 
women who received surgery was markedly lower among 
women aged between 18–34 years and who reported the 
least severe symptoms, than for women aged 45–49 years 
and who reported the most severe symptoms, among both 
those who had, and those who had not, received treat-
ment in primary care. Among the women who reported 
having had prior treatment in primary care, the propor-
tion receiving surgery among 18–34 year-olds with symp-
toms in the least severe quintile was 14% compared with 
70% of 45–49 year-olds with symptoms in the most severe 
quintile. Corresponding percentages among those who 
reported no prior treatment in primary care were 11% 
and 48%, respectively (figure 1). Adjusting for patient 
characteristics had only a small impact on the magni-
tude of the associations observed between both symptom 
severity and prior treatment in primary care and the rate 
of surgery.
Other characteristics were associated with the receipt 
of surgery although the magnitude of the associations 
was smaller than for symptom severity or prior treatment. 
Higher rates of surgical treatment were seen in women 
who had given birth, and those who had a higher BMI 
(25–30 or ≥30). Compared with white women, women 
reporting an Asian background had lower rates of surgery 
(RR 0.8, 95% CI 0.7 to 0.9), while women of black ethnic 
backgrounds had higher rates (RR 1.1, 95% CI 1.0 to 1.2, 
table 2). Socioeconomic deprivation was not associated 
with surgical treatment.
type of first surgical treatment received by women’s 
characteristics
Symptom severity was associated with having hysterectomy 
rather than EA (table 3). Among women who under-
went EA or a hysterectomy, the rate of hysterectomy was 
higher among those reporting the most severe symptoms 
compared with those reporting the least severe symptoms 
(RR comparing most vs least severe symptoms quintile 
1.6, 95% CI 1.3 to 1.8). Women who reported a longer 
duration of symptoms at their initial outpatient visit for 
HMB were more likely to have undergone a hysterectomy 
than EA (RR 1.2, 95% CI 1.1 to 1.4). Those who were 
obese (BMI 25–30) had higher rates of hysterectomy 
than those of a healthy weight (BMI <25) (RR 1.2, 95% CI 
1.1 to 1.3). Adjusting for patient characteristics had only 
a small impact on the magnitude of the associations 
Denominator (n=14 545)
% (n) unless 
otherwise 
stated
   Quintile 1 (least severe) 34.3 (10.8)
   Quintile 2 56.5 (4.4)
   Quintile 3 68.5 (2.6)
   Quintile 4 78.9 (3.4)
   Quintile 5 (most severe) 93.8 (5.1)
Duration of symptoms
  <1 year 26.1 (3677)
  ≥1 year 73.9 (10 434)
  Missing 3.0 (434)
Prior treatment for HMB in primary care
  No 30.4 (4296)
  Yes 69.6 (9819)
  Missing 3.0 (430)
*Index of Multiple Deprivation, an area-level measure of relative 
socioeconomic deprivation.
BMI, body mass index; HMB, heavy menstrual bleeding.
Table 1 Continued 
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Table 2 Characteristics associated with receiving surgical treatment in the first year following an initial outpatient visit for 
HMB
Denominator (n=14 545)
Received surgical 
treatment, % (n) Unadjusted risk ratio
Adjusted risk 
ratio 95% CI P value
Total 42.6 (6195)
Age group (years) <0.0001***
  18–34 18.4 (396) 0.37 0.37 0.33 to 0.41
  35–39 41.1 (774) 0.82 0.81 0.75 to 0.86
  40–44 49.9 (1932) 1.00 0.96 0.92 to 1.01
  45–49 49.9 (2273) 1 1 – 
  50–60 39.3 (820) 0.79 0.78 0.73 to 0.83
Ethnicity 0.0036**
  White 42.9 (5146) 1 1 – 
  Asian or Asian British 30.8 (176) 0.74 0.82 0.71 to 0.93
  Black or black British 49.0 (358) 1.14 1.10 1.00 to 1.21
  Other 39.1 (108) 0.91 0.98 0.84 to 1.14
Socioeconomic deprivation (IMD†) 0.2776
  Quintile 1 (most deprived) 41.7 (1424) 1 1 – 
  Quintile 2 41.2 (1300) 0.99 0.97 0.91 to 1.03
  Quintile 3 42.9 (1263) 1.03 1.02 0.96 to 1.09
  Quintile 4 44.5 (1211) 1.07 1.03 0.97 to 1.10
  Quintile 5 (least deprived) 43.3 (997) 1.04 1.02 0.95 to 1.09
BMI categories 0.0026**
  ≤25 38.8 (1715) 1 1 – 
  25–30 46.1 (1636) 1.19 1.09 1.04 to 1.14
  ≥30 45.9 (1480) 1.18 1.06 1.00 to 1.11
Parity 0.0076*
  Nulliparous 32.0 (760) 1 1 – 
  Parous 44.8 (5252) 1.40 1.09 1.02 to 1.17
Number of comorbidities 0.0712
  0 42.1 (4049) 1 1 – 
  1 43.7 (1618) 1.04 0.97 0.92 to 1.02
  ≥2 43.1 (528) 1.02 0.92 0.85 to 1.00
Severity score at baseline <0.0001***
  Quintile 1 (least severe) 33.1 (1233) 1 1 – 
  Quintile 2 39.9 (1437) 1.20 1.13 1.06 to 1.21
  Quintile 3 43.3 (1001) 1.31 1.24 1.16 to 1.33
  Quintile 4 49.6 (1292) 1.50 1.39 1.29 to 1.47
  Quintile 5 (most severe) 56.0 (1118) 1.69 1.53 1.43 to 1.64
Duration of symptoms at baseline <0.0001***
  <1 year 32.3 (1186) 1 1 – 
  ≥1 year 46.6 (4867) 1.45 1.28 1.21 to 1.36
Prior treatment for HMB in primary 
care <0.0001***
  No 31.1 (1335) 1 1 –
  Yes 48.0 (4709) 1.54 1.44 1.36 to 1.52
Multivariable model adjusted for age group, ethnicity, IMD, BMI, parity, number of comorbidities, baseline symptom severity and HMB 
treatment received in primary care. Categories compared using the Wald test. 
*P<0.05; **P<0.01; ***P<0.001.
†Index of Multiple Deprivation, an area-level measure of relative socioeconomic deprivation.
BMI, body mass index; HMB, heavy menstrual bleeding. 
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observed between both symptom severity, prior treatment 
in primary care and underlying condition and the likeli-
hood of receiving hysterectomy.
Women with an underlying condition diagnosed were 
more likely to have received a hysterectomy than women 
with no obvious cause of their HMB diagnosed. Women 
were twice as likely to have had a hysterectomy (RR 2.1, 
95% CI 1.9 to 2.4) if they had a diagnosis of uterine 
fibroids or polyps (without endometriosis) recorded, and 
four times more likely if they had endometriosis (with 
or without uterine fibroids or polyps) (RR 3.9, 95% CI 
3.4 to 4.5, table 3). Of women who received a hysterec-
tomy, 52.1% had a diagnosis of uterine fibroids or polyps 
(without endometriosis) recorded and 21.3% had endo-
metriosis (with or without uterine fibroids or polyps). In 
contrast, more than half of women undergoing EA had 
no obvious cause of their HMB diagnosed (52.9%; online 
supplementary appendix S4). There was no significant 
interaction between either ethnicity or BMI and under-
lying condition, although the power to detect a significant 
interaction in the complex relationship between ethnicity 
and HMB-related conditions would be small.
DIsCussIOn
Main findings
Approximately 40% of women referred to secondary care 
for HMB in England and Wales received a form of surgical 
treatment in the first year following their initial outpa-
tient clinic visit in secondary care. The rate of surgery was 
50% higher among women who reported having received 
treatment in primary care prior to their first outpatient 
visit than among those who did not. In addition, more 
severe symptoms were also associated with higher rates of 
surgery, and with receiving hysterectomy rather than EA. 
Women with an Asian ethnic background had lower rates 
of surgery, while women with a black ethnic background 
had higher rates of surgery, after adjusting for symptom 
severity than women with a white ethnic background. 
Socioeconomic deprivation was not associated with the 
rate of surgery.
Interpretation
We previously reported that socioeconomic deprivation 
influences access to secondary care for HMB16 as for 
other conditions.26 However, our findings illustrate that 
once women reach secondary care services, their receipt 
of surgical treatment depends mainly on their symptom 
severity, and whether or not they have received treatment 
in primary care prior to their referral. Nearly one-third 
of women reported that they had no treatment for their 
HMB in primary care and the chance that these women 
had surgery within the first year after their referral was 
considerably lower than for women who had prior 
treatment in primary care. National guidelines for the 
management of HMB in the UK indicate that hormonal 
or non-hormonal medical therapy can be started in 
primary care. Our findings suggest that this may reduce 
the number of potentially inappropriate referrals to 
specialist services.5 However, immediate referral can be 
appropriate for women seeking further diagnostic tests 
and reassurance, even without medical treatment.6 27–29 
In addition, some women may be referred immediately 
because they do not wish to take drug treatment, or it is 
anticipated that treatment available in primary care may 
fail to control their symptoms to an acceptable level.5
We also observed variation in surgery rates by ethnic 
background, after accounting for symptom severity. 
Compared with white women, women reporting Asian 
ethnicity had lower rates of surgery, and women reporting 
black ethnicity had higher rates of surgery. These differ-
ences may reflect inequitable use of surgical care, or may 
be attributable to variations according to ethnicity in the 
prevalence of HMB-related conditions (such as fibroids), 
cultural norms (eg, accepting heavy periods as normal) 
and patient preferences for treatment, which have been 
reported previously.30–32 We observed higher surgery rates 
among overweight and obese women, which may also be 
attributable to the prevalence of HMB-related conditions 
such as fibroids.33 34
Since 2004, more EA procedures than hysterectomies 
have been conducted in England.11 13 However, little was 
previously known about the determinants of hysterec-
tomy compared with EA. We have shown that the choice 
of procedure is strongly linked to symptom severity and 
HMB-related conditions, with a higher proportion of 
those who had worse symptoms, and those who had an 
underlying condition (uterine fibroids, polyps or endo-
metriosis) diagnosed receiving a hysterectomy. All women 
should have the opportunity to discuss the benefits and 
risks of both EA and hysterectomy, to help them make 
informed decisions about their treatment.5
Despite the existence of national guidelines for the 
management of HMB in the UK, developed by the National 
Institute for Health and Care Excellence and the Royal 
College of Obstetricians and Gynaecologists,5 30 35 only 
Figure 1 Receipt of surgery for heavy menstrual bleeding 
(HMB) based on prior treatment, age group and symptom 
severity quintile.
 o
n
 4 M
arch 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-024260 on 5 February 2019. Downloaded from 
7Geary RS, et al. BMJ Open 2019;9:e024260. doi:10.1136/bmjopen-2018-024260
Open access
Table 3 Characteristics associated with receiving hysterectomy (compared with endometrial ablation) in the first year 
following an initial outpatient visit for HMB
Denominator (n=5920)
Received 
hysterectomy, % (n)
Unadjusted risk 
ratio
Adjusted risk 
ratio 95% CI P value
Total 27.1 (1606)
Age group (years) 0.0713
  18–34 17.4 (62) 0.58 0.79 0.61 to 1.03
  35–39 25.5 (181) 0.83 0.84 0.71 to 0.99
  40–44 25.7 (478) 0.88 0.91 0.82 to 1.01
  45–49 29.9 (652) 1 1 – 
  50–60 29.1 (233) 0.97 0.88 0.77 to 1.01
Ethnicity 0.1184
  White 26.8 (1350) 1 1 – 
  Asian or Asian British 27.7 (44) 1.04 0.75 0.91 to 1.00
  Black or black British 34.9 (88) 1.30 1.13 1.09 to 1.39
  Other 32.6 (30) 1.20 0.88 0.62 to 1.26
Socioeconomic 
deprivation (IMD†) 0.3004
  Quintile 1 (most 
deprived) 28.2 (378) 1 1 – 
  Quintile 2 24.4 (298) 0.86 0.93 0.80 to 1.08
  Quintile 3 26.3 (319) 0.93 0.97 0.84 to 1.11
  Quintile 4 29.4 (344) 1.04 1.01 0.94 to 1.24
  Quintile 5 (least 
deprived) 27.4 (267) 0.97 1.03 0.89 to 1.19
BMI categories 0.0450*
  ≤25 24.7 (399) 1 1 – 
  25–30 29.7 (465) 1.20 1.15 1.03 to 1.29
  ≥30 28.0 (400) 1.13 1.08 0.96 to 1.21
Parity 0.2340
  Nulliparous 25.4 (165) 1 1 – 
  Parous 27.4 (1404) 1.09 0.95 0.82 to 1.10
Number of comorbidities 0.3223
  0 27.0 (1039) 1 1 – 
  1 26.5 (414) 0.98 0.97 0.86 to 1.08
  ≥2 29.9 (153) 1.11 1.12 0.95 to 1.32
Severity score at baseline 
(quintiles) <0.0001***
  Quintile 1 (least severe) 22.0 (251) 1 1 – 
  Quintile 2 26.0 (362) 1.18 1.17 1.00 to 1.37
  Quintile 3 28.2 (271) 1.28 1.26 1.07 to 1.49
  Quintile 4 26.3 (326) 1.20 1.23 1.05 to 1.43
  Quintile 5 (most severe) 33.9 (365) 1.54 1.57 1.34 to 1.83
Duration of symptoms at 
baseline 0.0078**
  <1 year 24.2 (273) 1 1 – 
  ≥1 year 28.0 (1304) 1.16 1.20 1.05 to 1.36
Prior treatment for HMB in 
primary care
0.0005***
Continued
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a minority of hospitals in England and Wales reported 
local protocols on the management of women with HMB 
to the National HMB Audit.36 Local auditing of referral 
pathways could help ensure that referrals to secondary 
care without prior treatment in primary care reflect 
patient-centred care.
strengths and limitations
A number of studies have reported treatment outcomes 
for women with HMB9 15 but our study is the first national 
study reporting on initial treatments for HMB immedi-
ately after referral to secondary care. It is also the first 
to examine the impact of sociodemographic factors and 
symptoms on the chance that women with HMB will 
receive surgical treatment. We used data collected by a 
national clinical audit in England and Wales, linked to 
administrative hospital data, which produced a large 
sample. We estimated that the National HMB Audit 
recruited approximately a third of all eligible women. 
While the recruitment rate was not as high as desired, 
the characteristics of those recruited were broadly repre-
sentative of the UK population in terms of ethnicity and 
age37 38 and the sample size was large. Information on 
women’s fertility intentions was not available, so we could 
not explore whether this influenced observed associa-
tions between age and ethnicity and receiving surgery.
COnClusIOns
Once women reach secondary care services, the chance 
that they will have surgical treatment within a year is 
strongly linked to their symptom severity and age and 
also, although less strongly, to their parity, BMI and ethnic 
background. Having received treatment in primary care 
before referral also increases the likelihood of surgery 
after referral. Our finding that a third of women were 
referred without prior treatment in primary care may 
raise questions about whether these referrals were appro-
priate. However, some women may benefit from referral 
for advice and further assessment, or may seek immediate 
surgical treatment. We recommend that referral pathways 
between primary and secondary care should be locally 
audited to ensure that the care that women with HMB 
receive addresses their individual needs and preferences.
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Denominator (n=5920)
Received 
hysterectomy, % (n)
Unadjusted risk 
ratio
Adjusted risk 
ratio 95% CI P value
  No 30.8 (389) 1 1 – 
  Yes 26.2 (1185) 0.86 0.80 0.71 to 0.89
HMB-related condition
  No obvious cause 14.7 (360) 1 1 – <0.0001***
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and/or polyps (no 
endometriosis) 30.6 (847) 1.99 2.11 1.86 to 2.41
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and HMB treatment received in primary care. A total of 699 women received both endometrial ablation (EA) and a hysterectomy in the year 
following their first outpatient visit. Here they are included in the EA group as this represents the first surgical treatment choice. Categories 
compared using the Wald test.
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BMI, body mass index; HMB, heavy menstrual bleeding. 
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